Skip to main content
. 2018 Dec 22;6(1):e000593. doi: 10.1136/bmjdrc-2018-000593

Figure 1.

Figure 1

Attrition diagram. Gla-300, insulin glargine 300 U/mL. aGla-300 claims in the identification period. bAfter applying inclusion/exclusion criteria listed in the text. Switcher: switching from another insulin; naïve: insulin-naïve; engagement level: amount of interaction with the COACH Program (‘2’ higher level of engagement than ’1’).